Maternal hepatitis B and infant infection among pregnant women living with HIV in South Africa

Journal of the International AIDS Society

Volumn 17, Issue , 2014, Pages

  Hoffmann, Christopher J ^a   Mashabela, Fildah ^b   Cohn, Silvia ^a   Hoffmann, Jennifer D ^a   Lala, Sanjay ^c   Martinson, Neil A ^a,b   Chaisson, Richard E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Africa; HBV; HIV; Occult hbv; Peripartum; Transmission; Vaccination

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADULT; AGE DISTRIBUTION; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; FEMALE; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT DISEASE; MAJOR CLINICAL STUDY; PREGNANT WOMAN; PRIORITY JOURNAL; SOUTH AFRICA; VACCINATION; VERTICAL TRANSMISSION;

AFRICA; HBV; HIV; OCCULT HBV; PERIPARTUM; TRANSMISSION; VACCINATION;

ADULT; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREVALENCE; SOUTH AFRICA;

EID: 84904893635     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.7448/IAS.17.1.18871     Document Type: Article

References (28)

1. Dienstag JL. Hepatitis B virus infection. N Engl J Med. 2008;359(14): 1486-500.
2. Hoffmann CJ, Thio CL. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis. 2007;7(6):402-9. (Pubitemid 46765200)
3. Schoub BD, Matai U, Singh B, Blackburn NK, Levin JB. Universal immunization of infants with low doses of a low-cost plasma-derived hepatitis B vaccine in South Africa. Bull WHO. 2002;80:277-81. (Pubitemid 34492287)
4. Hino K, Katoh Y, Vardas E, Sim J, Okita K, Carman WF. The effect of introduction of universal childhood hepatitis B immunization in South Africa on the prevalence of serologically negative hepatitis B virus infection and the selection of immune escape variants. Vaccine. 2001;19(28-29):3912-8. (Pubitemid 32566314)
5. Su WJ, Liu CC, Liu DP, Chen SF, Huang JJ, Chan TC, et al. Effect of age on the incidence of acute hepatitis B after 25 years of a universal newborn hepatitis B immunization program in Taiwan. J Infect Dis. 2012;205(5):757-62.
6. Li F, Wang Q, Zhang L, Su H, Zhang J, Wang T, et al. The risk factors of transmission after the implementation of the routine immunization among children exposed to HBV infected mothers in a developing area in northwest China. Vaccine. 2012;30(49):7118-22.
7. Cui FQ, Wang XJ, Cao L, Liang XF, Lu Y, Hu YS, et al. Progress in hepatitis B prevention through universal infant vaccination - China, 1997-2006. MMWR Morb Mortal Wkly Rep. 2007;56(18):441-5.
8. Vardas E, Mathai M, Blaauw D, McAnerney J, Coppin A, Sim J. Preimmunization epidemiology of hepatitis B virus infection in South African children. J Med Virol. 1999;58(2):111-5. (Pubitemid 29226851)
9. Abdool Karim SS, Thejpal R, Coovadia HM. Household clustering and intrahousehold transmission patterns of hepatitis B virus infection in South Africa. Int J Epidemiol. 1991;20(2):495-503.
10. Prozesky OW, Szmuness W, Stevens CE, Kew MC, Harley EJ, Hoyland JA, et al. Baseline epidemiological studies for a hepatitis B vaccine trial in Kangwane. S Afr Med J. 1983;64(23):891-3. (Pubitemid 14214500)
11. Tsebe KV, Burnett RJ, Hlungwani NP, Sibara MM, Venter PA, Mphahlele MJ. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds. Vaccine. 2001;19(28-29):3919-26. (Pubitemid 32566315)
12. Guidozzi F, Schoub BD, Johnson S, Song E. Should pregnant urban south African women be screened for hepatitis B? S Afr Med J. 1993;83(2):103-5. (Pubitemid 23092013)
13. Roingeard P, Diouf A, Sankale JL, Boye C, Mboup S, Diadhiou F, et al. Perinatal transmission of hepatitis B virus in Senegal, West Africa. Viral Immunol. 1993;6(1):65-73. (Pubitemid 23108509)
14. Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect Dis. 2002; 2(8):479-86. (Pubitemid 34826853)
15. Beasley RP, Hwang LY, Lin CC, Stevens CE, Wang KY, Sun TS, et al. Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial. Lancet. 1981;2(8243):388-93. (Pubitemid 11063765)
16. Pan CQ, Mi LJ, Bunchorntavakul C, Karsdon J, Huang WM, Singhvi G, et al. Tenofovir disoproxil fumarate for prevention of vertical transmission of hepatitis B virus infection by highly viremic pregnant women: a case series. Dig Dis Sci. 2012;57(9):2423-9.
17. Han GR, Cao MK, Zhao W, Jiang HX, Wang CM, Bai SF, et al. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J Hepatol. 2011;55(6):1215-21.
18. Reikie BA, Naidoo S, Ruck CE, Slogrove AL, de Beer C, la Grange H, et al. Antibody responses to vaccination among South African HIV-exposed and unexposed uninfected infants during the first 2 years of life. Clin Vaccine Immunol. 2013;20(1):33-8.
19. Jones CE, Naidoo S, de BC, Esser M, Kampmann B, Hesseling AC. Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. JAMA. 2011;305(6):576-84.
20. Firnhaber C, Reyneke A, Schulze D, Malope B, Maskew M, MacPhail P, et al. The prevalence of hepatitis B co-infection in a South African urban government HIV clinic. S Afr Med J. 2008;98(7):541-4.
21. Hoffmann CJ, Dayal D, Cheyip M, McIntyre JA, Gray GE, Conway S, et al. Prevalence and associations with hepatitis B and hepatitis C infection among HIV-infected adults in South Africa. Int J STD AIDS. 2012;23(10):e10-3.
22. Andersson MI, Maponga TG, Ijaz S, Theron G, Preiser W, Tedder RS. High HBV viral loads in HIV-infected pregnant women at a tertiary hospital, South Africa. J Acquir Immune Defic Syndr. 2012;60(4):e111-2.
23. Chasela CS, Kourtis AP, Wall P, Drobeniuc J, King CC, Thai H, et al. Hepatitis B virus infection among HIV-infected pregnant women in Malawi and transmission to infants. J Hepatol. 2014;60(3):508-14.
24. Mphahlele MJ, Lukhwareni A, Burnett RJ, Moropeng LM, Ngobeni JM. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa. J Clin Virol. 2006;35(1):14-20. (Pubitemid 43020947)
25. Firnhaber C, Viana R, Reyneke A, Schultze D, Malope B, Maskew M, et al. Occult hepatitis B virus infection in patients with isolated core antibody and HIV co-infection in an urban clinic in Johannesburg, South Africa. Int J Infect Dis. 2009;13(4):488-92.
26. Cohen Stuart JW, Velema M, Schuurman R, Boucher CA, Hoepelman AI. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy. J Med Virol. 2009;81(3): 441-5.
27. Barth RE, Huijgen Q, Tempelman HA, Mudrikova T, Wensing AM, Hoepelman AI. Presence of occult HBV, but near absence of active HBV and HCV infections in people infected with HIV in rural South Africa. J Med Virol. 2011;83(6):929-34.
28. Khamduang W, Ngo-Giang-Huong N, Gaudy-Graffin C, Jourdain G, Suwankornsakul W, Jarupanich T, et al. Prevalence, risk factors, and impact of isolated antibody to hepatitis B core antigen and occult hepatitis B virus infection in HIV-1-infected pregnant women. Clin Infect Dis. 2013;56(12):1704-12.